🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-1.10 (-8.27%)
Nov 20, 2026, 1:21 PM CST

GeneReach Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.11-110.28-118.73-166.27221.34376.62
Depreciation & Amortization
54.169.4473.7368.0364.2859.24
Other Amortization
1.661.661.010.860.890.77
Loss (Gain) From Sale of Assets
13.6413.528.171.39-1.7-0.41
Asset Writedown & Restructuring Costs
-13-----
Loss (Gain) From Sale of Investments
-5.619.052.572.53.73.81
Stock-Based Compensation
3.562.02----
Provision & Write-off of Bad Debts
-5.48-7.05-4.6521.43-1.135.06
Other Operating Activities
-5.11-11.72-1.35-66.17-65.6114.8
Change in Accounts Receivable
6.2510.74-16.9712.04138.08-31.15
Change in Inventory
-103.0914.8124.5916.07-91.29
Change in Accounts Payable
0.96-0.91.39-0.24-6.04-5.44
Change in Unearned Revenue
0.69-0.67-0.55-2.84-11.4913.17
Change in Other Net Operating Assets
-5.127.61-2.63-33.99-0.733.82
Operating Cash Flow
18.99-13.52-23.22-38.67357.63348.99
Operating Cash Flow Growth
----2.48%105.51%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.65-6.36-7.12-23.53-49.87-19.56
Sale of Property, Plant & Equipment
0.050.830.17-3.931.97
Sale (Purchase) of Intangibles
-2.63-6.01-1.34-3.82-0.59-1.36
Investment in Securities
32.99138.59-62.75-221.54-3.85
Other Investing Activities
1.93-0.060.84-1.02-1.48-26.61
Investing Cash Flow
19.69127-70.21-249.91-48.01-41.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-25913755--
Long-Term Debt Issued
-----198
Total Debt Issued
202.0925913755-198
Short-Term Debt Repaid
--294-70---2
Long-Term Debt Repaid
--11.19-47.58-201.94-19.35-8.82
Lease Payments
-11.49-11.19-11.78-11.94-11.85-8.82
Total Debt Repaid
-223.58-305.19-117.58-201.94-19.35-10.82
Net Debt Issued (Repaid)
-21.49-46.1919.42-146.94-19.35187.18
Repurchase of Common Stock
-8.43-17.31----
Common Dividends Paid
-----208.94-143.67
Other Financing Activities
--0.02-15.99-68.95--0.04
Financing Cash Flow
-29.92-63.523.43-215.89-228.2843.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
5.46-5.17-16.5-27.373.84-1.01
Net Cash Flow
14.2244.8-106.5-531.8485.18349.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6.34-19.87-30.35-62.21307.76329.43
Free Cash Flow Growth
-----6.58%206.11%
Free Cash Flow Margin
2.63%-8.54%-14.70%-27.59%41.03%32.55%
Free Cash Flow Per Share
0.11-0.35-0.53-1.085.195.62
Levered Free Cash Flow
141.67-10.08-68.7522.55262.91331.25
Unlevered Free Cash Flow
144.62-6.02-65.0426.15267.04335.16
Free Cash Flow After Leases
-5.15-31.06-42.12-74.14295.92320.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.736.645.544.564.585.26
Cash Income Tax Paid
-6.285.414.03117.3978.3
Change in Working Capital
-2.6619.87-3.9699.56135.88-110.9